Todd Stephenson

Todd Stephenson is an accomplished pharmaceutical sales professional with extensive experience in the biopharmaceutical industry, currently serving as the Associate Director of Key Accounts at TG Therapeutics, Inc. since February 2023. Notable prior positions include Rare Disease Specialty Account Manager at Horizon and Rare Disease Specialist at Akcea Therapeutics, where Todd received the 2019 Presidents Club award. Todd has a proven track record in launching innovative therapies, including ASO gene silencing technology for rare diseases, and possesses robust market development skills across multiple therapeutic specialties. Throughout a diverse career spanning over two decades, Todd has excelled in roles at various companies, including Braeburn Pharmaceuticals and Mallinckrodt Pharmaceuticals, demonstrating exceptional sales performance and leadership in multiple states. Todd holds a Bachelor of Science degree in Business from the University of Central Oklahoma.